1. Kurman RJ, Shih IM. The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory. Am J Surg Pathol. 2010;34:433-43.
2. Nezhat FR, Apostol R, Nezhat C, Pejovic T. New insights in the pathophysiology of ovarian cancer and implications for screening and prevention. American Journal of Obstetrics & Gynecology. 2015; 213:262-7.
3. Kim A, Ueda Y, Naka T, Enomoto T. Therapeutic strategies in epithelial ovarian cancer. Journal of Experimental, Clinical Cancer Research: CR. 2012;31:14.
4. Pakish JB, Jazaeri AA. Immunotherapy in Gynecologic Cancers: Are We There Yet? Curr. Treat. Options in Oncol. 2017;18:59.
5. Alves RM, Antonucci GA, Paiva HH, Cintra ACO, Franco JJ, Mendonça-Franqueiro EP, et al. Evidence of caspase-mediated apoptosis induced by l-amino acid oxidase isolated from Bothrops atrox snake venom. Comparative Biochemistry & Physiology Part A Molecular & Integrative Physiology. 2008; 151:542-50.
6. Bregge-Silva C, Nonato MC, Albuquerque SD, Ho PL, Azevedo ILMJD, Diniz MRV, et al. Isolation and biochemical, functional and structural characterization of a novel l-amino acid oxidase from Lachesis muta snake venom. Toxicon 60. 2012;1263-76.
7. Naumann GB, Silva LF, Silva L, Faria G, Richardson M, Evangelista K, et al. Cytotoxicity and inhibition of platelet aggregation caused by an l-amino acid oxidase from Bothrops leucurus venom. Biochim. Biophys. Acta. 2011;1810:683-94.
8. Sun LK, Yoshii Y, Hyodo A, Tsurushima H, Saito A, Harakuni T, et al. Apoptotic effect in the glioma cells induced by a specific protein extracted from Okinawa Habu (Trimeresurus flavoviridis) venom in relation to oxidative stress. Toxicol. In Vitro. 2003;17:169–77.
9. Guo C, Liu S, Yao Y, Zhang Q, Sun MZ. Past decade study of snake venom L-amino acid oxidase. Toxicon. 2012;60:302-11.
10. Tan KK, Bay HB, Gopalakrishnakone, Ponnampalam. L-amino acid oxidase from snake venom and its anticancer potential. Toxicon. 2018;144:7-13.
11. Zornig M, Hueber AO, Baum W, Evan G. Apoptosis regulators and their role in tumorigenesis. Biochim Biophys Acta. 2001;1551:F1-F37.
12. Hajra KM, Liu JR. Apoptosome dysfunction in human cancer. Apoptosis. 2004;9: 691-704.
13. Schmitz I, Kirchhoff S, Krammer PH. Regulation of death receptor-mediated apoptosis pathways. Int. J. Biochem. Cell Biol. 2000;32:1123–36.
14. Cory S, Adams JM. The Bcl2 family: Regulators of the cellular life-or-death switch. Nat. Rev. Cancer. 2002;2:647-56.
15. Walczak H, Krammer PH. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res. 2000;256:58–66.
16. Loeffler M, Kroemer G. The mitochondrion in cell death control: certainties and incognita. Exp Cell Res. 2000;256:19-26.
17. Villa-Morales M, Fernández-Piqueras J. Targeting the Fas/FasL signaling pathway in cancer therapy. Expert Opinion on Therapeutic Targets. 2012;16:85–101.
18. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;116:205-19.
19. Rodrigues RS, Silva JFD, Frana JB, Fonseca FPP, Rodrigues VM. Structural and functional properties of bp-laao, a new l-amino acid oxidase isolated from bothrops pauloensis snake venom. Biochimie. 2009;91:490-501.
20. Curti B. D- and L-amino acid oxidases. Chemistry & Biochemistry of Flavoenzymes. 1992;3:69-94.
21. Chaudhry P, Srinivasan R, Patel FD. Differential expression of Fas family members and Bcl-2 family members in benign versus malignant epithelial ovarian cancer (EOC) in North Indian population. Molecular & Cellular Biochemistry. 2012;368:119-26.
22. Duiker EW, Zee AGJVD, Graeff PD, Ek BV, Hollema H, Bock GHD, et al. The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer. Gynecol Oncol. 2010;116:549-55.
23. Yan L, Ya-Li H, Shan K, Rong-Miao Z, Bing-Li Q. Genetic polymorphisms in the fas and fasl genes are associated with epithelial ovarian cancer risk and clinical outcomes. Gynecologic Oncology. 2013;128:584–89.
24. Chang JS, Hsu YL, Kuo PL, Chiang LC, Lin CC. Upregulation of Fas/Fas ligand-mediated apoptosis by gossypol in an immortalized human alveolar lung cancer cell line. Clin Exp Pharmacol Physiol. 2004;31:716-22.
25. Rabinowich H, Reichert TE, Kashii Y, Gastman BR, Whiteside TL. Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes. J Clin Invest. 1998;101:2579-88.
26. Crnogorac-Jurcevic T, Efthimiou EC, Paola C, Blaveri E, Baron A, Terris B, et al. Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene. 2001;20:7437-46.
27. Cacan E. Histone Deacetylase-1-mediated Suppression of FAS in Chemoresistant Ovarian Cancer Cells. Anticancer Research. 2016;36:2819.
28. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase 8 to death receptors 4 and 5. Immunity. 2000;12:611-20.
29. Möröy T, Zörnig M. Regulators of life and death: the bcl-2 gene family. Cellular Physiology & Biochemistry. 2008;6:312-36.
30.Ni Chonghaile T, Sarosiek KA, Vo TT, Ryan JA, Tammareddi A, Moore VDG, Deng J, et al. Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science. 2011;334(6059):1129-33.
31. Roucou X, Rostovtseva T, Montessuit S, Martinou JC, Antonsson B. Bid induces cytochrome c-impermeable Bax channels in liposomes. Biochemical Journal. 2002;363:547-52.
32. Goncharenko-Khaider N, D Lane, Matte I, Rancourt C, A Piché. The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells. Oncogene. 2010; 29:5523–5536.
33. Cristofanon S, Fulda S. ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells. Cell Death Dis. 2012;3(11):e432.
34. Esposti MD. The roles of Bid. Apoptosis. 2002;7(5):433-40.
35. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309-12.
36. Xu L, Budihardjo I, Hua Z, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998;94:481–90.
37. Roby KF, Taylor CC, Sweetwood JP, Cheng Y, Pace JL, Ossama T, et al. Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis. 2000(4):585-91.
38. Izidoro LFM, Ribeiro MC, Souza GR, Sant’Ana CD, Hamaguchi A, Homsi-Brandeburgo MI, et al. Biochemical and functional characterization of an L-amino acid oxidase isolated from Bothrops pirajai snake venom. Bioorg Med Chem. 2006;14(20):7034–43.
39. Burin SM, Ayres LR, Neves RP, Ambrósio L, de Morais FR, Dias-Baruffi M, et al. L-amino acid oxidase isolated from Bothrops pirajai induces apoptosis in BCR-ABL-positive cells and potentiates imatinib mesylate effect. Basic Clin Pharmacol Toxicol. 2013;113(2):103–112.
40. Santos MMDV, Sant’Ana CD, Giglio JR, Silva RJD, Sampaio SV, Soares AM, et al. Antitumoural effect of an l-amino acid oxidase isolated from bothrops jararaca snake venom. Basic & Clinical Pharmacology & Toxicology. 2008;102:533-42.
41. Torii S, Yamane K, Mashima T, Haga N, Yamamoto K, Fox JW, et al. Molecular cloning and functional analysis of apoxin I, a snake venom-derived apoptosis-inducing factor with L-amino acid oxidase activity. Biochemistry. 2000;39:3197–205.
42. Matés JM, Sánchez-Jiménez FM. Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int. J. Biochem. Cell Biol. 2000;32:157-70.
43. Kanzawa N, Shintani S, Ohta K, Kitajima S, Ehara T, Kobayashi H, et al. Achacin induces cell death in HeLa cells through two different mechanisms. Arch. Biochem. Biophys. 2004;422:103-9.
44. Douglas RM, Haddad GG. Invited review: effect of oxygen deprivation on cell cycle activity: a profile of delay and arrest. J Appl Physiol. 2003;94(5):2068–83.
45.Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 2003;36(3):131–49.